Rate and Determinants of Completing Neoadjuvant Chemotherapy in Medicare Beneficiaries with Bladder Cancer: A SEER-Medicare Analysis

To determine the rate and determinants of neoadjuvant chemotherapy non-completion in patients with muscle-invasive bladder cancer.

Source: Urology - November 10, 2018 Category: Urology & Nephrology Authors: Lee A Hugar, Jonathan G Yabes, Robert M Turner, Mina M Fam, Leonard J Appleman, Benjamin J Davies, Bruce L Jacobs Source Type: research